Table 3.
Study design | Enrollment period | Ventilated HSCT patients (n) | PICU survival (%) | Long-term survival | Factors associated with mortality | Ref |
---|---|---|---|---|---|---|
Retrospective | 1983-1996 | 121 | 16 | N/A | Respiratory failure Pulmonary dysfunction >1 organ dysfunction |
97 |
Retrospective | 1990-1999 | 86 | 41 | 20% 2 yr | Hepatic dysfunction Use of HFOV |
98 |
Retrospective | 1991-2000 | 34 | 24 | N/A | Male gender MOF ≥ 3 Hemorrhagic cystitis GVHD Gr III-IV |
99 |
Prospective | 1993-2001 | 24 | 21 | 17% 1 yr | MOF | 100 |
Retrospective | 1994-1998 | 31 | 42 | 13% 6 mo | MV > 48 hours | 101 |
Retrospective | 1998-2001 | 13 | 15 | NR | MV > 5 days | 102 |
Retrospective | 1992-2004 | 65 | *59% | 54% 100 d | PaO2/FiO2 < 300 PEEP > 8 cm 24 hours No survivor HFOV |
103 |
Meta-analysis | 1973-2004 | 822 | 29% | N/A | Pulmonary infection | 104 |
Retrospective | 1996-2004 | 206 | 45% | 18% 6 mo | Previous intubation Within 6 months Hepatic/cardiac failure |
105 |
Retrospective | 2000-2006 | 36 | 31% | 25% 6 mo | MV > 7 days CRRT > 7 days Pressor support |
106 |
Retrospective | 2002-2009 | 28 | 31% | N/A | **Oxygenation index ≥ 25 associated with 100% mortality | 107 |
Retrospective | 2004-2010 | 88 | 39% | N/A | CRRT | 108 |
Abbreviations : PICU, pediatric intensive care-unit; N/A, not available; MOF, multi-organ failure; MV, mechanical ventilation; PEEP, positive-end expiratory pressure; CRRT, continuous renal replacement therapy; d, days; mo, months; yr, year.
During the period 2000-2004
Oxygenation index is defined as FiO2/PaO2 × mean airway pressure.